CTRI/2024/07/071372尚未招募4 期
A Prospective, Multicentric Post Marketing Surveillance (PMS) to Assess the Safety and Efficacy of Enzobiotics in CKD Patients- EETOX 2 - NI
Mylin Biotech India Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Subjects aged between 18- 70yrs
- •2.Stage 1 to Stage 5 with CKD.
- •3.Patient wanting to delay dialysis
- •4.Willing to come for regular follow -up visits
- •5.Able to give written informed consent
排除标准
- •5.Subjects with uncontrolled cardiovascular events.
- •6.Patients on other Pre- Probiotic therapy and with enzymes
- •7.Patients with acute coronary syndrome.
- •8.Patients who have been prescribed Synbiotics and Enzymes
- •9.Subjects with any other severe systemic illness and in the opinion of the investigator would be non-compliant with the visit schedule or study procedures
研究者
相似试验
尚未招募
4 期
Tofacitinib Tablets in the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative ColitisCTRI/2024/07/071353Sun Pharmaceutical Industries Limited (SPIL)
招募中
4 期
Post Marketing Observational Study to Assess Safety and suitability of Vildagliptin 100mg SR formulation in Type 2 Diabetes Mellitus (T2DM) patientsCTRI/2022/10/046453Abbott Healthcare Pvt Ltd
尚未招募
4 期
Post marketing surveillance of Aripiprazole tabletCTRI/2022/01/039860Torrent Pharmaceuticals Limited
进行中（未招募）
4 期
A post marketing study to monitor safety of Abiraterone Acetate (Zytiga) in Indian patients with Prostate CancerCTRI/2016/04/006854Johnson Johnson Private Limited
已完成
4 期
Post Marketing Study of Perampanel in Patients with EpilepsyCTRI/2019/01/016844Eisai Pharmaceutical India Limited200